Levocetirizine and montelukast in the treatment of inflammation mediated conditions Grant US-11590125-B2 United States of America 28 Feb 2023
Use of levocetirizine and montelukast in the treatment of autoimmune disorders Grant US-11344545-B2 United States of America 31 May 2022
Use of levocetirizine and montelukast in the treatment of traumatic injury Grant US-11103500-B2 United States of America 31 Aug 2021
Levocetirizine and montelukast in the treatment of inflammation mediated conditions Grant US-10792281-B2 United States of America 06 Oct 2020
Use of levocetirizine and montelukast to ameliorate inflammation following radiation… Grant US-10537568-B2 United States of America 21 Jan 2020
Use of levocetirizine and montelukast in the treatment of vasculitis Grant US-10206919-B2 United States of America 19 Feb 2019
Use of levocetirizine and montelukast in the treatment of autoimmune disorders Grant US-10201537-B2 United States of America 12 Feb 2019
Levocetirizine and montelukast in the treatment of inflammation mediated conditions Grant US-10195193-B2 United States of America 05 Feb 2019
Use of levocetirizine and montelukast in the treatment of traumatic injury Grant US-9937166-B2 United States of America 10 Apr 2018
Levocetirizine and montelukast in the treatment of inflammation mediated conditions Grant US-9925183-B2 United States of America 27 Mar 2018